Brenda Libby Coleman

Array ( [id] => 3787546 [patent_doc_number] => 05736540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Tricyclic diazepine vasopressin antagonists and oxytocin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/646841 [patent_app_country] => US [patent_app_date] => 1996-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60145 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 766 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736540.pdf [firstpage_image] =>[orig_patent_app_number] => 646841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770210 [patent_doc_number] => 05733905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Tricyclic diazepine vasopressin antagonists and oxytocin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/646582 [patent_app_country] => US [patent_app_date] => 1996-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60815 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 780 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733905.pdf [firstpage_image] =>[orig_patent_app_number] => 646582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726306 [patent_doc_number] => 05681957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Process for the preparation of substituted 2-fluoro-pyrimidines' [patent_app_type] => 1 [patent_app_number] => 8/643214 [patent_app_country] => US [patent_app_date] => 1996-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4177 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 326 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681957.pdf [firstpage_image] =>[orig_patent_app_number] => 643214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3880222 [patent_doc_number] => 05728829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Process of preparing benzodiazepine compounds useful as antagonists of CCK or of gastrine' [patent_app_type] => 1 [patent_app_number] => 8/591567 [patent_app_country] => US [patent_app_date] => 1996-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23803 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728829.pdf [firstpage_image] =>[orig_patent_app_number] => 591567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3793909 [patent_doc_number] => 05780498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Endothelin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/637720 [patent_app_country] => US [patent_app_date] => 1996-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33957 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780498.pdf [firstpage_image] =>[orig_patent_app_number] => 637720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828215 [patent_doc_number] => 05760031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Tricyclic benzazepine vasopressin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/637911 [patent_app_country] => US [patent_app_date] => 1996-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49949 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 472 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760031.pdf [firstpage_image] =>[orig_patent_app_number] => 637911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3877100 [patent_doc_number] => 05747487 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Tricyclic benzazepine vasopressin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/638067 [patent_app_country] => US [patent_app_date] => 1996-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50630 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 488 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747487.pdf [firstpage_image] =>[orig_patent_app_number] => 638067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787511 [patent_doc_number] => 05736538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Tricyclic Benzazepine vasopressin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/638059 [patent_app_country] => US [patent_app_date] => 1996-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52412 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 777 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736538.pdf [firstpage_image] =>[orig_patent_app_number] => 638059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3829222 [patent_doc_number] => 05739128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Tricyclic benzazepine vasopressin antagonists' [patent_app_type] => 1 [patent_app_number] => 8/637058 [patent_app_country] => US [patent_app_date] => 1996-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51167 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 996 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739128.pdf [firstpage_image] =>[orig_patent_app_number] => 637058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730748 [patent_doc_number] => 05703237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands' [patent_app_type] => 1 [patent_app_number] => 8/634278 [patent_app_country] => US [patent_app_date] => 1996-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5381 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/703/05703237.pdf [firstpage_image] =>[orig_patent_app_number] => 634278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4072506 [patent_doc_number] => 06069160 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Heteroatom-containing benzocyclopentane-oxazolidinones' [patent_app_type] => 1 [patent_app_number] => 8/631516 [patent_app_country] => US [patent_app_date] => 1996-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20400 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1008 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069160.pdf [firstpage_image] =>[orig_patent_app_number] => 631516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3762176 [patent_doc_number] => 05852023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Cyclohexylamino and cycloalkoxy nitrogen heterocycles, processes for their preparation, and their use as pesticides and fungicides' [patent_app_type] => 1 [patent_app_number] => 8/622741 [patent_app_country] => US [patent_app_date] => 1996-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18967 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 1295 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852023.pdf [firstpage_image] =>[orig_patent_app_number] => 622741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698273 [patent_doc_number] => 05677297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them' [patent_app_type] => 1 [patent_app_number] => 8/620213 [patent_app_country] => US [patent_app_date] => 1996-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18767 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677297.pdf [firstpage_image] =>[orig_patent_app_number] => 620213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3793315 [patent_doc_number] => 05726194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Endothelin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/617342 [patent_app_country] => US [patent_app_date] => 1996-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16193 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 282 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726194.pdf [firstpage_image] =>[orig_patent_app_number] => 617342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771497 [patent_doc_number] => 05849798 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Polyaromatic heterocyclic compounds and pharmaceutical/cosmetic compositions comprised thereof' [patent_app_type] => 1 [patent_app_number] => 8/615843 [patent_app_country] => US [patent_app_date] => 1996-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16692 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 704 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849798.pdf [firstpage_image] =>[orig_patent_app_number] => 615843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3895873 [patent_doc_number] => 05750525 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Quinoxalinedione derivatives, their production and use in pharmaceutical agents' [patent_app_type] => 1 [patent_app_number] => 8/537839 [patent_app_country] => US [patent_app_date] => 1996-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10224 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 537 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750525.pdf [firstpage_image] =>[orig_patent_app_number] => 537839 [rel_patent_id] =>[rel_patent_doc_number] =>)